EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Efferocytosis in Health and Disease

Chaofu Li iD, Yukun Yang iD, Fating Zhou iD, Qiuyan Jiang iD, Yingying Jiang iD, Xuanjie Huang, Yiqiong Zhang iD, Zhengmeng Ye iD, Gang Xu iD, Guoying Kao, Ke Zhou, Fan Yang iD und 3 weitere

MedComm · 2025-12 · 6 (12)

DOI: 10.1002/mco2.70546 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 14.12.2025. Verfasst von Chaofu Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology Chongqing Key Laboratory of Emergency Medicine Chongqing University Central Hospital (Chongqing Emergency Medical Center) Co…. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 246 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Chongqing Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Efferocytosis is the fundamental mechanism by which phagocytes clear apoptotic cells to maintain tissue homeostasis. This process is also closely linked to immune tolerance, metabolic reprogramming, inflammation resolution, and tissue repair. In recent years, research spanning cardiovascular disease, autoimmune disorders, metabolic inflammation, neurodegeneration, and cancer has revealed diverse context‐dependent regulatory networks, including “eat‐me” and “don't‐eat‐me” signals, phagocytic receptors, intracellular signaling pathways, and metabolic checkpoints. Disruption of these regulatory layers contributes to the defective resolution of inflammation, persistent immune activation, and impaired tissue regeneration. However, a unified comparative framework that integrates these mechanisms across different disease states is lacking. In this review, we provide a comprehensive overview of the biology of efferocytosis, from apoptotic cell recognition and engulfment to downstream immunometabolic rewiring. We highlight disease‐specific alterations in atherosclerosis, myocardial infarction, autoimmune diseases, neuroinflammation, and the tumor microenvironment. In addition, we summarize the emerging therapeutic strategies, including receptor agonists, metabolic interventions, engineered extracellular vesicles, and immune checkpoint modulation. Finally, we propose a “full‐cycle” monitoring strategy that integrates imaging‐based quantification, circulating biomarkers, multiomics profiling, and artificial intelligence to enable dynamic assessment of efferocytosis in vivo.

Schlagwörter

Stichwörter der Autor:innen

TAM receptorsapoptotic cell clearancebiomarker‐ and artificial intelligence‐based monitoringefferocytosisimmunometabolic rewiringprecision efferocytosis‐targeted therapy

Autor:innen und Institutionen

  • Department of Cardiology Chongqing Key Laboratory of Emergency Medicine Chongqing University Central Hospital (Chongqing Emergency Medical Center) College of Bioengineering Chongqing University Chongqing China.
  • Central Laboratory of Chongqing Emergency Medical Center Chongqing University Central Hospital School of Medicine Chongqing University Chongqing China.
  • Department of Neurology University Hospital Essen University of Duisburg-Essen Essen Germany.
  • Intensive Care Unit Chongqing University Central Hospital (Chongqing Emergency Medical Center) College of Bioengineering Chongqing University Chongqing China.
  • Stomatology Major in School of Stomatology Xinjiang Medical University Urumqi China.

ORCID-Profile: Chaofu Li, Yukun Yang, Fating Zhou, Qiuyan Jiang, Yingying Jiang, Yiqiong Zhang, Zhengmeng Ye, Gang Xu, Fan Yang, Jun Xiao, Wei Wu, Chuanwei Li

Förderung

  • Natural Science Foundation of Chongqing Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Li, C., Yang, Y., Zhou, F., Jiang, Q., Jiang, Y., Huang, X., Zhang, Y., Ye, Z., Xu, G., Kao, G., Zhou, K., Yang, F., Xiao, J., Wu, W., & Li, C. (2025). Efferocytosis in Health and Disease. MedComm, 6(12). https://doi.org/10.1002/mco2.70546

Vancouver

Li C, Yang Y, Zhou F, Jiang Q, Jiang Y, Huang X, et al. Efferocytosis in Health and Disease. MedComm. 2025;6(12). doi:10.1002/mco2.70546

BibTeX
@article{Li2025,
  author = {Li, Chaofu and Yang, Yukun and Zhou, Fating and Jiang, Qiuyan and Jiang, Yingying and Huang, Xuanjie and Zhang, Yiqiong and Ye, Zhengmeng and Xu, Gang and Kao, Guoying and Zhou, Ke and Yang, Fan and Xiao, Jun and Wu, Wei and Li, Chuanwei},
  title = {Efferocytosis in Health and Disease},
  journal = {MedComm},
  year = {2025},
  volume = {6},
  number = {12},
  doi = {10.1002/mco2.70546}
}
Kostenlos starten →